3S,7,11-Trimethyl-6E,10-dodecadienal
Common Name: |
3S,7,11-Trimethyl-6E,10-dodecadienal |
IUPAC Name: |
(3S,6E)-3,7,11-trimethyldodeca-6,10-dienal |
Molecular Formula: |
C11H16O3 |
SMILES: |
CC(CCC=C(C)CCC=C(C)C)CC=O |
Inchi: |
1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,12,15H,5-6,8,10-11H2,1-4H3/b14-9+/t15-/m0/s1 |
Inchi Key: |
ITBYWGRSPHMAEE-HNRFISLBSA-N |
Cas No: |
194934-66-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
196.24 |
Mass (g/mol) |
222.198 |
Molar Refractivity |
53.80 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
7 |
Rings |
|
TPSA |
39.44 |
Hetero Atoms |
1 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.55 |
LogP |
4.684 |
iLOGP |
2.58 |
XLOGP3 |
2.62 |
WLOGP |
2.75 |
MLOGP |
1.35 |
ESOL Log S |
-2.51 |
ESOL Solubility (mg/ml) |
0.607 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.10 |
Ali Solubility (mg/ml) |
0.16 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.71 |
Silicos-IT Solubility (mg/ml) |
0.04 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.64 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.717 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.259 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |